Description
Description
Tablets c modified-release film-coated 20mg: Round, biconvex tablets coated from yellow to orange. 50 mg film release coated tablets: Round, biconvex, dark red coated tablets. Syrup: a clear, colorless, viscous liquid with the smell of vanilla.
Latin name
Omnitus
Packing
10 pcs
Pharmacological action
Antitussive, has an expectorant, moderate bronchodilating and anti-inflammatory effect. Butamirate citrate is neither chemically nor pharmacologically related to opium alkaloids and has a direct effect on the cough center, improves spirometry and blood oxygenation.
Indications
Dry cough of any etiology (for colds, flu, whooping cough and other conditions). Cough suppression in the preoperative and postoperative period, during surgical interventions, bronchoscopy.
Contraindications
modified release tablets, film-coated: hypersensitivity, pregnancy, lactation, children under 6 years old – 20 mg tablets, up to 18 years old – 50 mg tablets.
Use during pregnancy and lactation
The use of the drug in the form of syrup during pregnancy is contraindicated, in the form of tablets in the first trimester of pregnancy.
If you need to use the drug during lactation, you should decide whether to stop breastfeeding.
Composition
1 tablet with a modified release coating film coating 20 mg contains:
Active ingredient
Butamirate citrate 20 mg
Excipients
Lactose monohydrate – 218.5 mg, hypromellose – 70.0 mg, 10.0 mg, 10.0 mg, magnesium stearate – 8.0 mg, colloidal silicon dioxide, anhydrous – 2.0 mg, povidone – 1.5 mg
Shell composition
Hypromellose – 5.105 mg, talc – 4, 700 mg, ethyl cellulose – 3.140 mg, macrogol – 1.253 mg, titanium dioxide – 1.041 mg, sunset sunset dye yellow [E 110] (11%) – 1.261 mg.
Dosage and Administration
Inside. Tablets are taken before meals, without chewing.
Tablets, 20 mg
Adults – 2 tablets 2-3 times a day
Children over 12 years old – 1 tab. 3 times a day from 6 to 12 years – 1 table. 2 times a day.
Side effects
Exanthema, nausea, diarrhea, dizziness, allergic reactions.
Overdose
Symptoms: nausea, vomiting, drowsiness, diarrhea, dizziness, decreased blood pressure.
Treatment: activated charcoal, salt laxatives, symptomatic therapy if necessary.
Storage conditions
Film-coated modified release tablets. Store in a dry, dark place at a temperature of 15 to 25 ° C.
Expiration
Modified-release tablets, film coated 20, 50 mg – 2 years.
Deystvuyuschee substances
butamirate
Dosage form
Dosage form
tablets prolong.
